OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut microbiome-bile acid axis in hepatocarcinogenesis
Liwei Wu, Jiao Feng, Jingjing Li, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111036-111036
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Lipid alterations in chronic liver disease and liver cancer
Bichitra Paul, Monika Lewińska, Jesper B. Andersen
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 196

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004779-e004779
Open Access | Times Cited: 104

How bile acids and the microbiota interact to shape host immunity
Michael H. Lee, Sean‐Paul Nuccio, Ipsita Mohanty, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 11, pp. 798-809
Closed Access | Times Cited: 19

Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
Rima Hajjo, Dima A. Sabbah, Abdel Qader Al Bawab
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1742-1742
Open Access | Times Cited: 48

Low-grade Chronic Inflammation: A Shared Mechanism for Chronic Diseases
Mariana Cifuentes, Hugo Verdejo, Pablo Castro, et al.
Physiology (2024) Vol. 40, Iss. 1, pp. 000-000
Closed Access | Times Cited: 9

The Gut-Liver Axis in Cholestatic Liver Diseases
Andreas Blesl, Vanessa Stadlbauer
Nutrients (2021) Vol. 13, Iss. 3, pp. 1018-1018
Open Access | Times Cited: 49

Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6
Zherui Liu, Yinyin Li, Chen Li, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 35

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35

Comparative evaluation of pseudocereal peptides: A review of their nutritional contribution
Muhammad Usman, Prasanna J. Patil, Arshad Mehmood, et al.
Trends in Food Science & Technology (2022) Vol. 122, pp. 287-313
Closed Access | Times Cited: 30

Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway
Qiang Yu, Weiqi Dai, Jie Ji, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 10, pp. 3031-3045
Open Access | Times Cited: 30

Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma
Annarosa Floreani, Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2194-2194
Open Access | Times Cited: 6

Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics
Vineet Singh, Kanika Mahra, Da-Ryung Jung, et al.
Probiotics and Antimicrobial Proteins (2024) Vol. 16, Iss. 5, pp. 1744-1761
Closed Access | Times Cited: 6

Crosstalk between PPARs and gut microbiota in NAFLD
Liwei Wu, Jingjing Li, Jiao Feng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111255-111255
Open Access | Times Cited: 37

Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma
Magdalena Stępień, Marina López‐Nogueroles, Agustín Lahoz, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 8, pp. 1255-1268
Open Access | Times Cited: 35

The altered lipidome of hepatocellular carcinoma
Shawn Lu Wen Tan, Erez Israeli, Russell Ericksen, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 445-456
Closed Access | Times Cited: 24

The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study
Guiyan Yang, Prasant Kumar Jena, Ying Hu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13

Ripened Pu-Erh Tea Improved the Enterohepatic Circulation in a Circadian Rhythm Disorder Mice Model
Shanshan Hu, Yu Chen, Sibo Zhao, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 45, pp. 13533-13545
Closed Access | Times Cited: 28

Ginsenoside, a potential natural product against liver diseases: a comprehensive review from molecular mechanisms to application
Sitong Shang, Haixia Yang, Linlin Qu, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-25
Closed Access

Gut microbiota in cancer: From molecular mechanisms to precision medicine applications
Weihua Xiao, Qiong Chen, Chunjiao Liu, et al.
iMeta (2025) Vol. 4, Iss. 2
Open Access

Role of Intestinal Microbes in Chronic Liver Diseases
Mengyi Xu, Kangkang Luo, Junjie Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12661-12661
Open Access | Times Cited: 17

Swainsonine Induces Liver Inflammation in Mice via Disturbance of Gut Microbiota and Bile Acid Metabolism
Keyi Fu, Xi Chen, Na Shou, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 3, pp. 1758-1767
Closed Access | Times Cited: 9

Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile
Carolina Miranda‐Vera, Ángela‐Patricia Hernández, Pilar Garcı́a Garcı́a, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2728-2728
Open Access | Times Cited: 9

Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma
Sancharan Acharya, Chinnasamy Thirunavukkarasu
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2, pp. 67-67
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top